You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 1, 2022

Cambodia Issues Law on Food Safety

On June 8, 2022, the King of Cambodia promulgated the Law on Food Safety by virtue of Royal Kram S/RKM/0622/006, ushering in a new dawn for food safety, consumer protection and investment in the food industry in Cambodia. The law addresses the complete food chain from farm to table and is set to bring Cambodia in line with international food safety standards.

The Law on Food Safety addresses a range of key issues for the food and beverage industry including technical regulations and minimum requirements; import controls; labeling; and inspection, competent authorities, and penalties. The Ministry of Commerce is tasked with coordinating the implementation and enforcement of the law, in cooperation with four other key ministries.

Food Technical Regulations

The law provides a framework for issuing legislative instruments mandating standards (Food Technical Regulations) generally based on existing practices in Cambodia, or on a regional or international level.

The law provides the legal bases for adopting Food Technical Regulations and appoints institutions that may adopt or request to adopt them. We expect many new Food Technical Regulations will be issued in the near future.

Food Requirements and Minimum Food Requirements

The law provides the following minimum requirements for food (Minimum Food Requirements):

  • Food must be safe for consumption;
  • Food may not be imported, manufactured, processed, or sold in a fraudulent or deceptive manner;
  • Consumers must receive “adequate information” as defined in the law, including information on the food’s origin, ingredients, nutritional value, calorific content, user guidelines, and storage guidelines.
  • Food must meet the minimum hygiene, packaging, and labelling requirements detailed in the law;
  • Food classified as high-risk must be properly registered; and
  • Storage of food must meet the safety and quality conditions set by the competent ministries.

Relevant ministries may issue new laws and regulations setting further legal requirements for food (Food Requirements) in accordance with Food Technical Regulations (if extant).

Food producers, processors, or packers must ensure that their products meet all relevant Food Technical Regulations, Minimum Food Requirements, and Food Requirements.

Furthermore, these types of businesses may not produce:

  1. Food unsafe for consumption;
  2. Counterfeit food, or food without providing an expiration date;
  3. Food with packaging and labelling that does not meet Cambodian standards on food labelling;
  4. Food with packaging that does not identify the manufacturer’s name and date; or
  5. Food that violates the Law on Food Safety in any way, or other provisions in force, or store such foods.

Similar rules are set for wholesalers and distributors of foods, but with a focus on food storage and transport. Retailers are also subject to a minimum set of rules under the Law on Food Safety that is similar, but with a focus on food storage and sales.

Labelling, Advertising, and Hygiene Requirements

All pre-packaged foods must have labelling that meets all applicable Minimum Food Requirements, Food Requirements, other duly issued laws and regulations on labelling, and Cambodian standards on food labelling.

All food labels must also:

  1. Provide tracing information;
  2. Use Khmer language, or at minimum provide information relating to food safety and consumer protection in Khmer (which may be on an affixed Khmer-language sticker if the original label is not in Khmer);
  3. Identify the “adequate information” discussed above, including nutritional information;
  4. Not contain any information, images, or trademarks that contradict the required information on the label, or that is confusing or misleading to consumers; and,
  5. Be legible and visible to the consumer when purchasing (i.e., not be covered by its packaging).

The law prohibits all false, deceptive, and confusing food advertising, with respect to:

  • Product expectation;
  • Identity, type, nature, place of origin, physical quality, or nutritional quality;
  • Quality, ingredient, quantity, date of production;
  • Expiry date, usage guidelines, and terms;
  • Methods of sales, product availability, and price; and,
  • Other warranties or assurances regarding the product.

Other prohibited acts in advertising will be determined by the Ministry of Commerce and other relevant ministries as deemed necessary from time to time.

These provisions are in line with the Law on Consumer Protection, which prohibits similar false, deceptive, and confusing advertising regarding all types of consumer products.

Food hygiene requirements will be further set by implementing regulations, with the Law on Food Safety merely requiring food businesses to meet such requirements when issued.

Importation of Food

Imported foods must meet the Minimum Food Requirements and Food Requirements, and any requirements found in existing legislation.

Importers must provide an authorization certificate for imported foods, issued by the competent authorities of the exporting country, in accordance with risk management principles and pursuant to the applicable laws and relevant regulations of the exporting country.

The list of food products subject to this requirement, the required documentation, and any further importation requirements, will be determined by a sub-decree to be issued at a later date.

Laboratory analysis of imported foods may be required if the authorities deem it necessary.

Imported foods that are not compliant may be subject to:

  • Re-export;
  • Requirements for the importer to change the product to meet the legal requirements, including new labelling, followed by a re-examination; or,
  • Destruction.

All costs are incurred by the importer in these circumstances.

Food Inspection and Inspectors

This law authorizes food inspectors to inspect the market for compliance. Inspectors may inspect any type of food businesses and have powers to enter premises to do so. If necessary, they may take products for laboratory testing.

Lastly, the law outlines several penalties for violations, including fines and imprisonment. Stiff penalties apply to those who intentionally trade products containing harmful ingredients and chemicals, including up to 15 years imprisonment in cases that result in deaths.

Analysis

The Law on Food Safety, and the clarity it provides to the food industry and to consumers, is a welcome addition to Cambodia’s consumer protection regime. The adoption of this law is in line with the government’s recent focus on consumer protection, marked by the adoption of the Law on Consumer Protection, the Law on E-Commerce, and implementing regulations, such as the Prakas on Unfair Contract Clauses.

The most impactful immediate change for many food industry companies is that Khmer food labelling is now (at least partially) required, which was not standard practice in the market. Although the previous legal framework did require Khmer labelling, this regulation was either not clear, or was not duly enforced. We expect enforcement efforts to ramp up now that food inspectors have new powers of inspection and enforcement.

The requirement for nutritional values and calories on food labelling is also a substantial change to current practices, which will contribute greatly to the protection of consumers and will provide for a fairer playing field for businesses.

We eagerly await further implementing regulations surrounding imported foods, and especially further clarity on product registration requirements. It appears that registration of all types of pre-packaged food products is still required under existing laws and regulations. However, with the new law only addressing product registration requirements for high-risk products (and potentially imported products), we are keen to see how these registration requirements will be applied.

RELATED INSIGHTS​ 

September 3, 2025
Liberal cannabis access in Thailand is officially over. On June 26, 2025, the Ministry of Public Health brought the inflorescence of cannabis back under tight control through its new Notification on Controlled Herbs (Cannabis) 2025 (“Notification 2025”). The message is that cannabis may stay in the marketplace, but only if strictly supervised under a cannabis prescription from a medical professional. Two main pillars now define compliance: (1) prescription requirements and mandatory reporting, and (2) Good Agricultural and Collection Practices (GACP). This article aims to summarize each essential element for the relevant parties. 1. Getting a Prescription: Digital Diagnosis vs. Real-World Paperwork? Dispensaries, even those with a license to sell cannabis, can no longer sell cannabis to walk-in customers who don’t have a valid prescription. Sales are lawful only when the buyer duly presents a cannabis prescription issued by one of seven recognized professional practitioners, including medical doctors, Thai traditional medicine doctors, applied Thai traditional medicine doctors, folk healers, Chinese medicine practitioners, pharmacists, or dentists. Notification 2025 does not mention teleconsultations or online prescriptions. Nonetheless, policymakers at this stage opine that an online chat or casual consultation, with the prescription sent via a social media platform or e-mail, would not comply with this latest regulation. In order to be eligible to issue cannabis prescriptions, medical doctors should be working in a clinic or hospital and should issue paper-based prescriptions. The official prescription form, called a PT 33, must be used. The prescriber has the discretion to indicate the cannabis strain (or product type), dosage, and intended duration of use, which cannot exceed 30 days per prescription. This ensures that the product matches the patient’s medical needs and aligns with professional treatment guidelines. In practice, each prescription will be valid for one-time use only and cannot be refilled; a new prescription
August 8, 2025
In response to persistent challenges in food safety management and recent high-profile incidents involving counterfeit supplemented foods, infant formula, and health supplements, the Ministry of Health of Vietnam is initiating comprehensive regulatory reforms. These reforms include proposed amendments to the Law on Food Safety and its implementing Decree No. 15/2018/ND-CP (Decree 15), introducing significant changes to the registration procedures for food products, especially supplemented food products and health supplements. While awaiting public consultation and approval of the amended Law on Food Safety, the Ministry of Health is developing an interim mechanism, which includes a draft decree to replace Decree 15 and a draft resolution to address urgent issues until the amended law becomes effective, expected in July 2026. To align with the new Law on Quality of Products and Goods, the draft resolution stipulates that the declaration and registration of food products will follow the following procedures: Declaration of applied standards for food products, which is currently known as the “self-declaration” procedure, applies to processed packaged foods, food additives, food processing aids, containers or utensils that come into direct contact with food, packaging materials in direct contact with food, and micronutrients. Granting of circulation numbers, which is the current “registration of product declaration” procedure, applies to specific categories of food including health supplements, medical nutrition foods, special dietary foods, nutritional products for children up to 36 months, and, especially, supplemented foods, which are currently subject to self-declaration but will be shifted to this registration procedure. In addition, the following new procedure is introduced in the draft decree: Registration of declaration of conformity, which applies to the same product category as in “declaration of applied standards” above, but is for products that are already subject to technical regulations covering both safety indicators and quality indicators. Changes to the Food Product
July 15, 2025
On July 1, 2025, Vietnam’s Ministry of Health issued Circular No. 30/2025/TT-BYT providing updated guidance on the application of drug quality standards, testing of drugs and pharmaceutical ingredients, and procedures for the recall and handling of noncompliant drugs (Circular 30). Circular 30 officially came into effect on the same day and replaces Circular No. 11/2018/TT-BYT and its amendments. Key highlights of Circular 30 are presented below. Drug and Pharmaceutical Ingredient Quality Standards Circular 30 maintains consistency with previous regulations regarding the selection of an applicable quality specification. Pharmaceutical businesses and drug preparation establishments may still choose to apply standards from the Vietnamese Pharmacopoeia, reference pharmacopoeias (including the United States Pharmacopoeia, the European Pharmacopoeia, the British Pharmacopoeia, the Japanese Pharmacopoeia, and the International Pharmacopoeia), or an in-house specification. Priority is given to the Vietnamese Pharmacopoeia and reference pharmacopoeias, encompassing quality indicators, quality levels, and testing methods. If alternative pharmacopoeias or in-house specifications are used, they must meet the requirements outlined in the corresponding monographs of the Vietnamese or reference pharmacopoeias. At the time of registration, the quality standards of drugs and pharmaceutical ingredients must comply with either the current version of the pharmacopoeia or a previous version of the pharmacopoeia that is no more than two years older than the current version. The requirement for updating quality specifications in line with the quality under the corresponding pharmacopoeia also applies to products that have already been granted marketing authorization. Testing Drugs and Pharmaceutical Ingredients in Quality Management Similar to the regulations under the previous circular, if pharmaceutical businesses disagree with the sample testing results, they may, within five working days of receiving the test report, request that the state quality inspection authority designate an alternative testing facility. The testing period for establishments listed as foreign drug manufacturers with quality violations remains
July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support